{"result": "(\"entity\"<|>CYSTIC FIBROSIS<|>EVENT<|>Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to severe respiratory and nutritional challenges.)\n##\n(\"entity\"<|>RIORDAN JR<|>PERSON<|>Riordan JR is a researcher known for his work in identifying the cystic fibrosis gene and its implications.)\n##\n(\"entity\"<|>SOUTHERN KW<|>PERSON<|>Southern KW is a researcher who conducted a survey of newborn screening for cystic fibrosis in Europe.)\n##\n(\"entity\"<|>FARRELL PM<|>PERSON<|>Farrell PM is a researcher who studied the prevalence of cystic fibrosis in the European Union.)\n##\n(\"entity\"<|>BALLMANN M<|>PERSON<|>Ballmann M is a researcher involved in clinical trials related to diabetes management in cystic fibrosis patients.)\n##\n(\"entity\"<|>EUROPE<|>GEO<|>Europe is a continent where various studies and surveys regarding cystic fibrosis have been conducted.)\n##\n(\"relationship\"<|>RIORDAN JR<|>CYSTIC FIBROSIS<|>Riordan JR identified the cystic fibrosis gene, which is crucial for understanding the disease<|>9)\n##\n(\"relationship\"<|>SOUTHERN KW<|>CYSTIC FIBROSIS<|>Southern KW conducted a survey on newborn screening for cystic fibrosis, contributing to early detection efforts<|>8)\n##\n(\"relationship\"<|>FARRELL PM<|>CYSTIC FIBROSIS<|>Farrell PM researched the prevalence of cystic fibrosis, providing important epidemiological data<|>8)\n##\n(\"relationship\"<|>BALLMANN M<|>CYSTIC FIBROSIS<|>Ballmann M conducted a trial comparing diabetes treatments in cystic fibrosis patients, linking the two conditions<|>7)\n##\n(\"relationship\"<|>SOUTHERN KW<|>EUROPE<|>Southern KW's survey was focused on newborn screening for cystic fibrosis across Europe<|>6)\n##\n(\"relationship\"<|>FARRELL PM<|>EUROPE<|>Farrell PM's research on cystic fibrosis prevalence was conducted within the European context<|>6)\n##\n(\"relationship\"<|>BALLMANN M<|>EUROPE<|>Ballmann M's clinical trial was part of a broader research effort in Europe regarding cystic fibrosis and diabetes<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: diabéticos 1500mL al día |\n| 2017 | 157 | 40,5 | 16,4 | 8,3 | = |\n| 2018 | 157,5 | 42,9 | 17,3 | 7,2 | Fórmula polimérica HC (1.5kcaL/ml) HP específica para diabéticos 1000mL |\n\n## Tabla 2: Clasificación de las alteraciones hidrocarbonadas en FQ\n\n| CATEGORÍA | GLUCEMIA BASAL | GLUCEMIA A LAS 2H DE LA SOG |\n|-----------|----------------|---------------------------|\n| TOLERANCIA NORMAL A LA GLUCOSA | < 100 mg/dl (5,6 mmol/l) | < 140 mg/dl (7,8 mmol/l) |\n| GLUCEMIA ALTERADA EN AYUNAS (GBA) | 100-125 mg/dl (5,6-7 mmol/l) | - |\n| TOLERANCIA INDETERMINADA A LA GLUCOSA (INDET) | < 100 mg/dl (5,6 mmol/l) | < 140 mg/dl (7,8 mmol/l) con una glucemia previa > 200 mg/dl (11,1 mmol/l) |\n| INTOLERANCIA A LOS HIDRATOS DE CARBONO (IHC) | < 100 mg/dl (5,6 mmol/l) | Entre 140 y 200 mg/dl (7,8 a 11,1 mmol/l) |\n| DRFQ | < 126 mg/dl (7 mmol/l) | > 200 mg/dl (11,1 mmol/l) |\n---\n\n## Tabla 3. Causas de desnutrición en FQ\n\n| AUMENTO DEL GASTO ENERGÉTICO | DISMINUCIÓN DE LA INGESTA | AUMENTO DE LAS PÉRDIDAS |\n|------------------------------|---------------------------|--------------------------|\n| ENFERMEDAD PULMONAR: <br>- Inflamación crónica <br>- Colonización bacteriana <br>- Infecciones recurrentes | ANOREXIA: <br>- Infección crónica: aumento de producción de moco <br>- Antibióticos | INSUFICIENCIA PANCREÁTICA EXOCRINA |\n| INSUFICIENCIA PANCREÁTICA | REFLUJO GASTROESOFÁGICO | HEPATOPATÍA RELACIONADA CON LA FQ: alteración de sales biliares |\n| DEFECTO DEL REGULADOR DE LA CONDUCTANCIA TRANSMEMBRANA | ESTREÑIMIENTO | DIABETES RELACIONADA CON LA FQ (descompensada) |\n| | SÍNDROME DE OBSTRUCCIÓN INTESTINAL DISTAL | SOBRECRECIMIENTO BACTERIANO |\n| | SOBRECRECIMIENTO BACTERIANO | |\n| | ALTERACIÓN DE LA MOTILIDAD INTESTINAL | |\n\n## Tabla 4. Composición de las diferentes fórmulas de NE\n\n| COMPOSICIÓN | FÓRMULA ESTÁNDAR | FÓRMULA DIABETES | FÓRMULA PEPTÍDICA |\n|-------------|-------------------|-------------------|---------------------|\n| Aporte de HC | Alto (>50%) | Bajo (<50%) | Alto (50-69%) |\n| Tipo de HC | Sencillos | Complejos | Sencillos |\n| Índice Glucémico | Alto | Bajo | Alto |\n| Aporte de grasa | Bajo (≈30%) | Alto (>30%) | Bajo (15-30%) |\n| Tipo de grasa | LCT | MUFA, n-3 | MCT (≈70%) |\n| Aporte de fibra | Bajo o nulo | Alto | Nulo |\n| Tipo de fibra | - | Soluble, prebiótico | - |\n| Aporte de proteínas | 15-20% | 15-25% | 18-21% |\n| Fuente proteica | Leche | Soja | Proteínas hidrolizadas (péptidos) |\n| Otros | Bajo coste | Mejor control glucémico | Osmolaridad elevada (>400mOsm/l) |\n---\n# Bibliografía\n\n1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066-73.\n\n2. Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, et al. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros. 2007;6:57e65.\n\n3. Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7:450e3.\n\n4. Ballmann M, Hubert D, Assael BM, et al. Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial. Lancet Diabetes Endocrinol. 2018;6(\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}